Ximedica, which is based in Providence, said the buyout gives it an important foothold on the West Coast. Last November, venture capital firm SV Life Sciences acquired a majority stake in Ximedica.
Ximedica, a Medtech development firm, has acquired San Francisco-based Bridge Design for an undisclosed amount.
“This partnership has been formed to broaden the strength, reach and scale of Ximedica’s comprehensive development offering,” said Randall Barko, Ximedica president and CEO, in prepared remarks. “Ximedica brings the regulated systems, procedures and expertise to complement Bridge Design’s 2-plus decades of award-winning design in medtech. By combining these strengths, we bring high value to our clients, offering a cost-effective development approach and a depth of expertise aligned with industry trends for digitally connected solutions.”
Ximedica, which is based in Providence, said the buyout gives it an important foothold on the West Coast. Last November, venture capital firm SV Life Sciences acquired a majority stake in Ximedica.
“By joining forces with Ximedica we will be able to respond to an increasing demand from our client base for a more comprehensive offering. We believe this will resonate deeply as major growth areas like mHealth build strength. In addition, we are looking forward to scaling our team and talent and fueling a common hunger to solve substantive design problems with elegant and engaging solutions,” said Bill Evans, Bridge Design founder and president.
Ximedica
www.ximedica.com
Bridge Design
www.bridgedesign.com
